Women in Path

Our all-female panel are still taking your questions on the biggest career issues that women face in the lab. Get in touch via Twitter using #WomenInPath or email below to be part of an upcoming article!

Tweet of the week

Take a look at our favorite tweet from last week:

The Translational Scientist sits at the leading edge of bench-to-bedside research, celebrating translation today – and exploring the inside track on the innovations set to revolutionize tomorrow...

With the emergence of a new class of targeted precision oncology therapies, NTRK fusions are increasingly becoming biomarkers that pathology laboratories can test for in FFPE tumor tissue. Although different testing options exist such as IHC or FISH, NGS seems to be the preferred choice based on new guidelines.